PapersPMID:25765835
Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial.
- findings
- 4
- compound
- 1
- endpoints
- 4
- Study, every finding
- RCT · 6 weeks
- Dose studied, every finding
- 140 mg dried Silybum marianum extract three times daily for 45 days
What moved
How to read these marks →“Silymarin supplementation significantly increased superoxide dismutase (SOD), glutathione peroxidase (GPX) activity and total antioxidant capacity (TAC) compared to patients taking the placebo, by 12.85%, 30.32% and 8.43%, respectively (p < 0.05).”
- Increases superoxide dismutase activity
very limited
- Population
- adults aged 25-50 with type 2 diabetes mellitus on stable medication
- Increases glutathione peroxidase activity
very limited
- Population
- adults aged 25-50 with type 2 diabetes mellitus on stable medication
- Increases total antioxidant capacity
very limited
- Population
- adults aged 25-50 with type 2 diabetes mellitus on stable medication
- Decreases C-reactive protein concentration
very limited
“There was a significant reduction in hs-CRP levels by 26.83% (p < 0.05) in the silymarin group compared to the placebo group.”
- Population
- adults aged 25-50 with type 2 diabetes mellitus on stable medication; fasting blood samples
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- type 2 diabetes patients aged 25-50 yr on stable medication (Tabriz, Iran)
- Participants
- 40
- Comparator
- placebo
- Duration
- 45 days
- Endpoints measured
- 5